Nicholas J. Shaheen

ORCID: 0000-0001-6602-5647
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Eosinophilic Esophagitis
  • Gastric Cancer Management and Outcomes
  • Gastroesophageal reflux and treatments
  • Helicobacter pylori-related gastroenterology studies
  • Eosinophilic Disorders and Syndromes
  • Gastrointestinal Tumor Research and Treatment
  • Colorectal Cancer Screening and Detection
  • Cancer-related gene regulation
  • Gastrointestinal disorders and treatments
  • Dysphagia Assessment and Management
  • IL-33, ST2, and ILC Pathways
  • Tracheal and airway disorders
  • Metastasis and carcinoma case studies
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Pancreatic and Hepatic Oncology Research
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • HIV/AIDS Research and Interventions
  • Lung Cancer Treatments and Mutations
  • Gastrointestinal motility and disorders
  • Foreign Body Medical Cases
  • Diverticular Disease and Complications

University of North Carolina at Chapel Hill
2016-2025

Communities In Schools of Orange County
1997-2024

Kalasalingam Academy of Research and Education
2024

Oregon Medical Research Center
2024

New York Proton Center
2024

University of Pittsburgh
2024

Lindsay Unified School District
2024

University of North Carolina Health Care
2005-2023

Indiana University School of Medicine
2005-2019

RELX Group (Netherlands)
2019

Barrett's esophagus (BE) is among the most common conditions encountered by gastroenterologist. In this document, American College of Gastroenterology updates its guidance for best practices in caring these patients. These guidelines continue to endorse screening high-risk patients BE; however, routine limited men with reflux symptoms and multiple other risk factors. Acknowledging recent data on low malignant progression nondysplastic BE, endoscopic surveillance intervals are attenuated...

10.1038/ajg.2015.322 article EN The American Journal of Gastroenterology 2015-11-03

ACG: American College of Gastroenterology; ADR: adenoma detection rate; APC: per colonoscopy; ASGE: Society for Gastrointestinal Endoscopy; CRC: colorectal cancer; PDR: polyp rate Colonoscopy is widely used the diagnosis and treatment colon disorders. Properly performed, colonoscopy generally safe, accurate, well-tolerated. Visualization mucosa entire large intestine distal terminal ileum usually possible during colonoscopy. Polyps can be removed colonoscopy, thereby reducing risk cancer....

10.1038/ajg.2014.385 article EN The American Journal of Gastroenterology 2014-12-02

Background & AimsGastrointestinal (GI), liver, and pancreatic diseases are a source of substantial morbidity, mortality, cost in the United States. Quantification statistical analyses burden these important for researchers, clinicians, policy makers, public health professionals. We gathered data from national databases to estimate GI liver disease States.MethodsWe collected statistics on care utilization ambulatory inpatient setting along with cancers mortality 2007 through 2012. included...

10.1053/j.gastro.2015.08.045 article EN public-domain Gastroenterology 2015-08-29

BACKGROUND Digestive and liver diseases are a source of significant morbidity, mortality, health-care costs for the U.S. population. An annual report toll these could be helpful to clinicians, policymakers, researchers. AIM To describe epidemiology gastrointestinal in United States using data from privately publicly held databases. METHODS We collected National Center Health Statistics, Ambulatory Medical Care Survey, Inpatient Sample, Centers Disease Control Prevention, Cancer Institute, as...

10.1111/j.1572-0241.2006.00723.x article EN The American Journal of Gastroenterology 2006-07-18

10.1053/j.gastro.2012.04.032 article EN Gastroenterology 2012-04-24

Antiretroviral drugs are found at different concentrations in human cervical, vaginal, and rectal mucosal tissues with implications for designing PrEP trials to prevent HIV transmission.

10.1126/scitranslmed.3003174 article EN Science Translational Medicine 2011-12-07
Coming Soon ...